Spots Global Cancer Trial Database for Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

Official Title: A Multicenter Randomized Phase II Trial in NSCLC Stage IV and IIIB (T4 With Pleural Effusion) in Elderly Independent Patients the Schedule Docetaxel / Gemcitabine First Line Following by Erlotinib When Progression Versus Erlotinib First Line Following by/ Gemcitabine When Progression.

Study ID: NCT00418704

Conditions

Non Small Cell Lung Cancer

Interventions

Erlotinib

taxotere

Study Description

Brief Summary: The purpose of this study is to determine duration before progression of first-line treatment chemotherapy following erlotinib in second-line comparing erlotinib in first-line following chemotherapy in second-line in old patients with none small cell lung cancer.

Detailed Description: A multicenter phase II trial , prospective, randomized, open, non comparative